Cargando…

A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates

BACKGROUND AND AIMS: Adeno-associated virus (AAV) vectors are widely used to deliver therapeutic transgenes to distinct tissues, including the liver. Vectors based on naturally occurring AAV serotypes as well as vectors using engineered capsids have shown variations in tissue tropism and level of tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stone, Daniel, Meumann, Nadja, Kuhlmann, Anne-Sophie, Peterson, Christopher W., Xie, Hong, Roychoudhury, Pavitra, Loprieno, Michelle A., Vu, Xuan-Khang, Strongin, Daniel E., Kenkel, Elizabeth J., Haick, Anoria, Stensland, Laurence, Obenza, Willimark M., Parrott, Jacob, Nelson, Veronica, Murnane, Robert D., Huang, Meei-Li, Aubert, Martine, Kiem, Hans-Peter, Büning, Hildegard, Jerome, Keith R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503678/ https://www.ncbi.nlm.nih.gov/pubmed/37074875 http://dx.doi.org/10.1097/HC9.0000000000000009

Ejemplares similares

Gene editing and elimination of latent herpes simplex virus in vivo
por: Aubert, Martine, et al.
Publicado: (2020)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

In Vivo Murine-Matured Human CD3(+) Cells as a Preclinical Model for T Cell-Based Immunotherapies
por: Haworth, Kevin G., et al.
Publicado: (2017)

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
por: Meumann, Nadja, et al.
Publicado: (2023)

Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies
por: Colón-Thillet, Rossana, et al.
Publicado: (2023)

Modifying immune responses to adeno-associated virus vectors by capsid engineering
por: Bentler, Martin, et al.
Publicado: (2023)

Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates
por: Addetia, Amin, et al.
Publicado: (2020)

Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
por: Meumann, Nadja, et al.
Publicado: (2022)

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
por: Hacker, Ulrich T., et al.
Publicado: (2020)

Differentiated phenotypes of primary murine alveolar epithelial cells and their susceptibility to infection by respiratory viruses
por: Kebaabetswe, Lemme P., et al.
Publicado: (2013)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations
por: Schnödt, Maria, et al.
Publicado: (2016)

Gene Delivery to Nonhuman Primate Preimplantation Embryos Using Recombinant Adeno‐Associated Virus
por: Wang, Dan, et al.
Publicado: (2019)

Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
por: Rossi, Axel, et al.
Publicado: (2019)

In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia
por: Dang, Chung H., et al.
Publicado: (2017)

Adeno-associated virus type 2 (AAV2) uncoating is a stepwise process and is linked to structural reorganization of the nucleolus
por: Sutter, Sereina O., et al.
Publicado: (2022)

Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
por: Bartel, Melissa, et al.
Publicado: (2011)

SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98
por: Addetia, Amin, et al.
Publicado: (2021)

Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors
por: Hösel, Marianna, et al.
Publicado: (2017)

CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
por: Stone, Daniel, et al.
Publicado: (2020)

Gene therapy enters the pharma market: The short story of a long journey
por: Büning, Hildegard
Publicado: (2013)

Validation of SARS-CoV-2 detection across multiple specimen types
por: Perchetti, Garrett A., et al.
Publicado: (2020)

Neurofilament light chain and dorsal root ganglia injury after adeno-associated virus 9 gene therapy in nonhuman primates
por: Johnson, Eric W., et al.
Publicado: (2022)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
por: Pavlou, Marina, et al.
Publicado: (2021)

The Role of the Adeno-Associated Virus Capsid in Gene Transfer
por: Van Vliet, Kim M., et al.
Publicado: (2008)

Adeno-associated virus capsid assembly is divergent and stochastic
por: Wörner, Tobias P., et al.
Publicado: (2021)

Detection of Adeno-Associated Virus Viremia in Hematopoietic Cell Transplant Recipients
por: Heugel, Judson, et al.
Publicado: (2011)

DNA Barcoding in Nonhuman Primates Reveals Important Limitations in Retrovirus Integration Site Analysis
por: Adair, Jennifer E., et al.
Publicado: (2020)

Differential Effects of HOXB4 on Nonhuman Primate Short- and Long-Term Repopulating Cells
por: Zhang, Xiao-Bing, et al.
Publicado: (2006)

Ex Vivo/In vivo Gene Editing in Hepatocytes Using “All-in-One” CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template
por: Krooss, Simon Alexander, et al.
Publicado: (2019)

Rational Design of Gene Therapy Vectors
por: Pan, Dao, et al.
Publicado: (2019)

Skeletal muscle-directed gene therapy: hijacking the fusogenic properties of muscle cells
por: Büning, Hildegard, et al.
Publicado: (2023)

A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies
por: Humbert, Olivier, et al.
Publicado: (2017)

Nonhuman and Nonhuman-Human Communication: Some Issues and Questions
por: Pepperberg, Irene M.
Publicado: (2021)

Adeno-Viren
por: Falke, Dietrich
Publicado: (2009)

Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering
por: Sen, Dwaipayan
Publicado: (2014)

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors
por: Bertin, Berangere, et al.
Publicado: (2020)

Chemical modification of the adeno-associated virus capsid to improve gene delivery
por: Mével, Mathieu, et al.
Publicado: (2019)

Electrophoresis-Mediated Characterization of Full and Empty Adeno-Associated Virus Capsids
por: Coll De Peña, Adriana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qebglgc58gltovgjeoovg2vate